Last updated on October 2018

Genetics and Heart Health After Cancer Therapy

Brief description of study

The overall objective of this study is to use patient-centered in vitro and in vivo models to answer the fundamental question of whether or not pathogenic mutations in BRCA1/2 result in an increased risk of CV disease

Clinical Study Identifier: NCT03510689

Find a site near you

Start Over